前列腺癌超低分割放疗后的生活质量:RTOG 0938试验的挑战

Therapeutic radiology and oncology Pub Date : 2019-02-25 DOI:10.21037/tro.2019.02.01

S. Arcangeli, V. Pinzi

{"title":"前列腺癌超低分割放疗后的生活质量:RTOG 0938试验的挑战","authors":"S. Arcangeli, V. Pinzi","doi":"10.21037/tro.2019.02.01","DOIUrl":null,"url":null,"abstract":"In the Red Journal , Lukka and colleagues reported optimal quality of life (QoL) outcomes of the NRG Oncology RTOG 0938 trial (1). This trial randomly compared two short radiation schedules of 5 and 12 fractions of 7.25 and 4.3 Gy each, respectively, for the treatment of localized, low risk prostate cancer. The primary endpoint was the proportion of patients with a change in bowel and urinary EPIC-50 score at 1-year.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/tro.2019.02.01","citationCount":"0","resultStr":"{\"title\":\"Quality of life after ultra-hypofractionated radiotherapy for prostate cancer: the challenge of RTOG 0938 trial\",\"authors\":\"S. Arcangeli, V. Pinzi\",\"doi\":\"10.21037/tro.2019.02.01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In the Red Journal , Lukka and colleagues reported optimal quality of life (QoL) outcomes of the NRG Oncology RTOG 0938 trial (1). This trial randomly compared two short radiation schedules of 5 and 12 fractions of 7.25 and 4.3 Gy each, respectively, for the treatment of localized, low risk prostate cancer. The primary endpoint was the proportion of patients with a change in bowel and urinary EPIC-50 score at 1-year.\",\"PeriodicalId\":93236,\"journal\":{\"name\":\"Therapeutic radiology and oncology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.21037/tro.2019.02.01\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic radiology and oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/tro.2019.02.01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic radiology and oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/tro.2019.02.01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

在《红色杂志》上，Lukka及其同事报道了NRG肿瘤学RTOG 0938试验的最佳生活质量(QoL)结果(1)。该试验随机比较了两种短辐射方案，分别为5分和12分，分别为7.25 Gy和4.3 Gy，用于治疗局部低风险前列腺癌。主要终点是1年时肠和尿EPIC-50评分发生变化的患者比例。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Quality of life after ultra-hypofractionated radiotherapy for prostate cancer: the challenge of RTOG 0938 trial

In the Red Journal , Lukka and colleagues reported optimal quality of life (QoL) outcomes of the NRG Oncology RTOG 0938 trial (1). This trial randomly compared two short radiation schedules of 5 and 12 fractions of 7.25 and 4.3 Gy each, respectively, for the treatment of localized, low risk prostate cancer. The primary endpoint was the proportion of patients with a change in bowel and urinary EPIC-50 score at 1-year.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Therapeutic radiology and oncology

CiteScore

0.50

自引率

0.00%

发文量